Black Cohosh Does Not Exert an Estrogenic Effect on the Breast
Authors:
- 7 November 2007
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 59 (2) , 269-277
Abstract
Women's Health Initiative findings indicate that hormone replacement therapy may increase breast cancer and cardiovascular disease risk. Black cohosh extract (BCE) is a popular alternative that reduced menopausal symptoms in several clinical trials. Preclinical studies have addressed the estrogenic properties of BCE, with conflicting results. The estrogenic influence of BCE on the breast has not been investigated. Black cohosh is standardized to triterpenes, but the activity and mechanism of action of these compounds are unknown. The study goals were to determine 1) triterpene content of 2 commercially available BCE preparations and 2) the effect of BCE on circulating and breast-specific estrogenic markers. Two black cohosh preparations were analyzed for triterpene content. Postmenopausal women took BCE for 12 wk followed by a 12-wk washout. One BCE preparation contained trace amounts and another contained 2.5% triterpenes. Women taking BCE with 2.5% triterpenes experienced relief of menopausal symptoms, with reversion toward baseline after washout. BCE had no effect on estrogenic markers in serum and no effect on pS2 or cellular morphology in nipple aspirate fluid. Triterpene content in commercially available black cohosh preparations varies. BCE standardized to 2.5% triterpenes relieved menopausal symptoms without systemic or breast-specific estrogenic effects.Keywords
This publication has 36 references indexed in Scilit:
- Addressing the Soy and Breast Cancer Relationship: Review, Commentary, and Workshop ProceedingsJNCI: Journal of the National Cancer Institute, 2006
- Evaluation of the Botanical Authenticity and Phytochemical Profile of Black Cohosh Products by High-Performance Liquid Chromatography with Selected Ion Monitoring Liquid Chromatography−Mass SpectrometryJournal of Agricultural and Food Chemistry, 2006
- Efficacy and Safety of Isopropanolic Black Cohosh Extract for Climacteric SymptomsObstetrics & Gynecology, 2005
- Efficacy ofCimicifuga racemosaon climacteric complaints: A randomized study versus low-dose transdermal estradiolGynecological Endocrinology, 2005
- Methods of phytochemical standardisation of rhizoma Cimicifugae racemosaePhytochemical Analysis, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Isolation, Structure Elucidation, and Absolute Configuration of 26-Deoxyactein from Cimicifuga racemosa and Clarification of Nomenclature Associated with 27-DeoxyacteinJournal of Natural Products, 2002
- Two-Week Dietary Soy Supplementation Has an Estrogenic Effect on Normal Premenopausal BreastThe Journal of Clinical Endocrinology & Metabolism, 1999
- Effects of Extracts fromCimicifuga racemosaon Gonadotropin Release in Menopausal Women and Ovariectomized RatsPlanta Medica, 1991
- Untersuchungen zur endokrinen Wirksamkeit von Inhaltsstoffen ausCimicifuga racemosa2.In vitro-Bindung von Inhaltsstoffen an ÖstrogenrezeptorenPlanta Medica, 1985